Amir Valizadeh

10PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersReproduction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 19, 2026
Celastrol Enhanced Doxorubicin-Mediated Apoptosis in Saos-2 Osteosarcoma Cells.

|Apr 10, 2026
Celastrol overcomes 5-fluorouracil resistance in osteosarcoma cells through p53-mediated apoptotic pathway modulation and P-glycoprotein inhibition: A comprehensive mechanistic study.

Mohammad Ebrahimnezhad, Amir Valizadeh, Bahman Yousefi

|Mar 17, 2026
Synergistic Effects of Curcumin and Temozolomide in Overcoming Glioblastoma Drug Resistance through Regulation of O6-Methylguanine-DNA Methyltransferase, Mismatch Repair, and Poly(Adenosine Diphosphate Ribose) Polymerase 1.

Masoud Sohrabi, Amir Valizadeh, Mehran Molavand

|Nov 26, 2025
Gallic Acid Induces Apoptosis in Oral Squamous Cell Carcinoma via PI3K/AKT/mTOR Pathway Inhibition and PTEN Upregulation: an In Vitro Study.

Sanaz Helli, Armin Heidari, Armin Tafvizi

|Nov 18, 2025
Diosgenin Enhances the Sensitivity to Methotrexate Through Oxidative DNA Damage in Saos-2 Osteosarcoma Cancer Cells.

Hadi Ghobadi, Amir Valizadeh, Mohsen Dashti

|Apr 24, 2025
Enhancing Doxorubicin Sensitivity in Osteosarcoma Cancer Cells: Unveiling the Role of Resveratrol-Induced Oxidative DNA Damage.

Mohammad Reza Bazavar, Hamed Helali, Linda Mohammadzadeh Boukani

Pageof 2

Frequent Collaborators

8 joint publications

Bahman Yousefi

2 joint publications

Mohammad Ebrahimnezhad

1 joint publications

Mohammad Nouri

1 joint publications

Masoud Darabi